• Register
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.


Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.


Long-term course of L-dopa-responsive dystonia caused by tyrosine hydroxylase deficiency.

The authors report the long-term course of two siblings with L-dopa responsive dystonia (DRD) associated with a compound heterozygous mutation in the tyrosine hydroxylase (TH) gene. Both siblings manifested with lower-limb onset generalized DRD and had a sustained response to low-dose L-dopa therapy for over 35 years. Although the l-dopa therapy was delayed up to 20 years after disease onset, there were no cognitive or neurologic sequelae of the long-term catecholamine deficit.

Pubmed ID: 15505183


  • Schiller A
  • Wevers RA
  • Steenbergen GC
  • Blau N
  • Jung HH



Publication Data

October 26, 2004

Associated Grants


Mesh Terms

  • Adult
  • Age of Onset
  • Brain
  • Brain Chemistry
  • Catecholamines
  • DNA Mutational Analysis
  • Disease Progression
  • Dopamine Agents
  • Dystonia
  • Heterozygote
  • Humans
  • Levodopa
  • Longitudinal Studies
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Panic Disorder
  • Point Mutation
  • Siblings
  • Time
  • Tyrosine 3-Monooxygenase